Global Acute Liver Failure Treatment Market Research Report 2024

Report ID: 1881890 | Published Date: Sep 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Liver Failure Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hepatocyte Transplantation
        1.2.3 Assisted Liver Transplantation
        1.2.4 Xenotransplantation
    1.3 Market by Application
        1.3.1 Global Acute Liver Failure Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Liver Academic and Research Institutes
        1.3.5 Forensic Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Liver Failure Treatment Market Perspective (2017-2028)
    2.2 Acute Liver Failure Treatment Growth Trends by Region
        2.2.1 Acute Liver Failure Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Liver Failure Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Acute Liver Failure Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Acute Liver Failure Treatment Market Dynamics
        2.3.1 Acute Liver Failure Treatment Industry Trends
        2.3.2 Acute Liver Failure Treatment Market Drivers
        2.3.3 Acute Liver Failure Treatment Market Challenges
        2.3.4 Acute Liver Failure Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Liver Failure Treatment Players by Revenue
        3.1.1 Global Top Acute Liver Failure Treatment Players by Revenue (2017-2022)
        3.1.2 Global Acute Liver Failure Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Liver Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Liver Failure Treatment Revenue
    3.4 Global Acute Liver Failure Treatment Market Concentration Ratio
        3.4.1 Global Acute Liver Failure Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Liver Failure Treatment Revenue in 2021
    3.5 Acute Liver Failure Treatment Key Players Head office and Area Served
    3.6 Key Players Acute Liver Failure Treatment Product Solution and Service
    3.7 Date of Enter into Acute Liver Failure Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Liver Failure Treatment Breakdown Data by Type
    4.1 Global Acute Liver Failure Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Acute Liver Failure Treatment Forecasted Market Size by Type (2023-2028)
5 Acute Liver Failure Treatment Breakdown Data by Application
    5.1 Global Acute Liver Failure Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Acute Liver Failure Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Liver Failure Treatment Market Size (2017-2028)
    6.2 North America Acute Liver Failure Treatment Market Size by Country (2017-2022)
    6.3 North America Acute Liver Failure Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Liver Failure Treatment Market Size (2017-2028)
    7.2 Europe Acute Liver Failure Treatment Market Size by Country (2017-2022)
    7.3 Europe Acute Liver Failure Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Liver Failure Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Acute Liver Failure Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Liver Failure Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Liver Failure Treatment Market Size (2017-2028)
    9.2 Latin America Acute Liver Failure Treatment Market Size by Country (2017-2022)
    9.3 Latin America Acute Liver Failure Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Liver Failure Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Company Detail
        11.1.2 Novartis AG Business Overview
        11.1.3 Novartis AG Acute Liver Failure Treatment Introduction
        11.1.4 Novartis AG Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.1.5 Novartis AG Recent Development
    11.2 Bayer AG
        11.2.1 Bayer AG Company Detail
        11.2.2 Bayer AG Business Overview
        11.2.3 Bayer AG Acute Liver Failure Treatment Introduction
        11.2.4 Bayer AG Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.2.5 Bayer AG Recent Development
    11.3 Cardiorentis AG
        11.3.1 Cardiorentis AG Company Detail
        11.3.2 Cardiorentis AG Business Overview
        11.3.3 Cardiorentis AG Acute Liver Failure Treatment Introduction
        11.3.4 Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.3.5 Cardiorentis AG Recent Development
    11.4 Cytokinetics, Inc.
        11.4.1 Cytokinetics, Inc. Company Detail
        11.4.2 Cytokinetics, Inc. Business Overview
        11.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Introduction
        11.4.4 Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.4.5 Cytokinetics, Inc. Recent Development
    11.5 Orion Corporation
        11.5.1 Orion Corporation Company Detail
        11.5.2 Orion Corporation Business Overview
        11.5.3 Orion Corporation Acute Liver Failure Treatment Introduction
        11.5.4 Orion Corporation Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.5.5 Orion Corporation Recent Development
    11.6 Bristol-Myers Squibb Company
        11.6.1 Bristol-Myers Squibb Company Company Detail
        11.6.2 Bristol-Myers Squibb Company Business Overview
        11.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Introduction
        11.6.4 Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Company Recent Development
    11.7 PhaseBio Pharmaceuticals, InC
        11.7.1 PhaseBio Pharmaceuticals, InC Company Detail
        11.7.2 PhaseBio Pharmaceuticals, InC Business Overview
        11.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Introduction
        11.7.4 PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.7.5 PhaseBio Pharmaceuticals, InC Recent Development
    11.8 Merck & Co
        11.8.1 Merck & Co Company Detail
        11.8.2 Merck & Co Business Overview
        11.8.3 Merck & Co Acute Liver Failure Treatment Introduction
        11.8.4 Merck & Co Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.8.5 Merck & Co Recent Development
    11.9 CVie Therapeutics Limited
        11.9.1 CVie Therapeutics Limited Company Detail
        11.9.2 CVie Therapeutics Limited Business Overview
        11.9.3 CVie Therapeutics Limited Acute Liver Failure Treatment Introduction
        11.9.4 CVie Therapeutics Limited Revenue in Acute Liver Failure Treatment Business (2017-2022)
        11.9.5 CVie Therapeutics Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Acute Liver Failure Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hepatocyte Transplantation
    Table 3. Key Players of Assisted Liver Transplantation
    Table 4. Key Players of Xenotransplantation
    Table 5. Global Acute Liver Failure Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Acute Liver Failure Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Acute Liver Failure Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Acute Liver Failure Treatment Market Share by Region (2017-2022)
    Table 9. Global Acute Liver Failure Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Acute Liver Failure Treatment Market Share by Region (2023-2028)
    Table 11. Acute Liver Failure Treatment Market Trends
    Table 12. Acute Liver Failure Treatment Market Drivers
    Table 13. Acute Liver Failure Treatment Market Challenges
    Table 14. Acute Liver Failure Treatment Market Restraints
    Table 15. Global Acute Liver Failure Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Acute Liver Failure Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2021)
    Table 18. Ranking of Global Top Acute Liver Failure Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Acute Liver Failure Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Acute Liver Failure Treatment Product Solution and Service
    Table 22. Date of Enter into Acute Liver Failure Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Acute Liver Failure Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Acute Liver Failure Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Acute Liver Failure Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Acute Liver Failure Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Acute Liver Failure Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Acute Liver Failure Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Acute Liver Failure Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Acute Liver Failure Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Novartis AG Company Detail
    Table 43. Novartis AG Business Overview
    Table 44. Novartis AG Acute Liver Failure Treatment Product
    Table 45. Novartis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 46. Novartis AG Recent Development
    Table 47. Bayer AG Company Detail
    Table 48. Bayer AG Business Overview
    Table 49. Bayer AG Acute Liver Failure Treatment Product
    Table 50. Bayer AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 51. Bayer AG Recent Development
    Table 52. Cardiorentis AG Company Detail
    Table 53. Cardiorentis AG Business Overview
    Table 54. Cardiorentis AG Acute Liver Failure Treatment Product
    Table 55. Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 56. Cardiorentis AG Recent Development
    Table 57. Cytokinetics, Inc. Company Detail
    Table 58. Cytokinetics, Inc. Business Overview
    Table 59. Cytokinetics, Inc. Acute Liver Failure Treatment Product
    Table 60. Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 61. Cytokinetics, Inc. Recent Development
    Table 62. Orion Corporation Company Detail
    Table 63. Orion Corporation Business Overview
    Table 64. Orion Corporation Acute Liver Failure Treatment Product
    Table 65. Orion Corporation Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 66. Orion Corporation Recent Development
    Table 67. Bristol-Myers Squibb Company Company Detail
    Table 68. Bristol-Myers Squibb Company Business Overview
    Table 69. Bristol-Myers Squibb Company Acute Liver Failure Treatment Product
    Table 70. Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 71. Bristol-Myers Squibb Company Recent Development
    Table 72. PhaseBio Pharmaceuticals, InC Company Detail
    Table 73. PhaseBio Pharmaceuticals, InC Business Overview
    Table 74. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Product
    Table 75. PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 76. PhaseBio Pharmaceuticals, InC Recent Development
    Table 77. Merck & Co Company Detail
    Table 78. Merck & Co Business Overview
    Table 79. Merck & Co Acute Liver Failure Treatment Product
    Table 80. Merck & Co Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 81. Merck & Co Recent Development
    Table 82. CVie Therapeutics Limited Company Detail
    Table 83. CVie Therapeutics Limited Business Overview
    Table 84. CVie Therapeutics Limited Acute Liver Failure Treatment Product
    Table 85. CVie Therapeutics Limited Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million)
    Table 86. CVie Therapeutics Limited Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Liver Failure Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Hepatocyte Transplantation Features
    Figure 3. Assisted Liver Transplantation Features
    Figure 4. Xenotransplantation Features
    Figure 5. Global Acute Liver Failure Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Liver Academic and Research Institutes Case Studies
    Figure 9. Forensic Laboratories Case Studies
    Figure 10. Acute Liver Failure Treatment Report Years Considered
    Figure 11. Global Acute Liver Failure Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Acute Liver Failure Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Acute Liver Failure Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Acute Liver Failure Treatment Market Share by Players in 2021
    Figure 15. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Acute Liver Failure Treatment Revenue in 2021
    Figure 17. North America Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Acute Liver Failure Treatment Market Share by Country (2017-2028)
    Figure 19. United States Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Acute Liver Failure Treatment Market Share by Country (2017-2028)
    Figure 23. Germany Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Acute Liver Failure Treatment Market Share by Region (2017-2028)
    Figure 31. China Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Acute Liver Failure Treatment Market Share by Country (2017-2028)
    Figure 39. Mexico Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Acute Liver Failure Treatment Market Share by Country (2017-2028)
    Figure 43. Turkey Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Novartis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 46. Bayer AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 47. Cardiorentis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 48. Cytokinetics, Inc. Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 49. Orion Corporation Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 51. PhaseBio Pharmaceuticals, InC Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 52. Merck & Co Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 53. CVie Therapeutics Limited Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis AG
Bayer AG
Cardiorentis AG
Cytokinetics, Inc.
Orion Corporation
Bristol-Myers Squibb Company
PhaseBio Pharmaceuticals, InC
Merck & Co
CVie Therapeutics Limited
Frequently Asked Questions
Acute Liver Failure Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Liver Failure Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Liver Failure Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Flying Bikes

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Oil Storage Terminal

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More